Latest Insider Transactions at Dbv Technologies S.A. (DBVT)
This section provides a real-time view of insider transactions for Dbv Technologies S.A. (DBVT). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of DBV Technologies S.A. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of DBV Technologies S.A.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Nov 25
2024
|
Pharis Mohideen Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
565
-0.51%
|
$0
$0.57 P/Share
|
|
Nov 22
2024
|
Pharis Mohideen Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
342
-0.31%
|
$0
$0.53 P/Share
|
|
Nov 21
2024
|
Virginie Boucinha Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
19,000
+33.33%
|
-
|
|
Nov 21
2024
|
Pharis Mohideen Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
2,350
-2.05%
|
$0
$0.54 P/Share
|
|
Nov 21
2024
|
Pharis Mohideen Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
35,000
+23.43%
|
-
|
|
Jul 29
2024
|
Pharis Mohideen Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
1,785
-2.2%
|
$0
$0.98 P/Share
|
|
May 24
2024
|
Pharis Mohideen Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
660
-0.81%
|
$660
$1.36 P/Share
|
|
May 22
2024
|
Pharis Mohideen Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
382
-0.46%
|
$382
$1.38 P/Share
|
|
Mar 08
2024
|
Daniel Tasse CHIEF EXECUTIVE OFFICER |
BUY
Open market or private purchase
|
Direct |
17,094
+50.0%
|
$0
$0.83 P/Share
|
|
Feb 06
2024
|
Adora Ndu |
BUY
Open market or private purchase
|
Direct |
1,825
+50.0%
|
$0
$0.89 P/Share
|
|
Nov 22
2023
|
Pharis Mohideen Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
2,245
-2.66%
|
$2,245
$1.74 P/Share
|
|
Nov 20
2023
|
Virginie Boucinha Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
19,000
+50.0%
|
-
|
|
Nov 20
2023
|
Pharis Mohideen Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
35,000
+29.3%
|
-
|
|
Aug 25
2023
|
Timothy E Morris Director |
BUY
Open market or private purchase
|
Direct |
12,000
+50.0%
|
$12,000
$1.52 P/Share
|
|
Aug 01
2023
|
Daniel B Soland Director |
BUY
Open market or private purchase
|
Direct |
15,000
+42.86%
|
$15,000
$1.62 P/Share
|
|
May 24
2023
|
Pharis Mohideen Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
469
-0.94%
|
$1,407
$3.54 P/Share
|
|
Nov 24
2022
|
Pharis Mohideen Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
1,792
-3.47%
|
$3,584
$2.88 P/Share
|
|
Nov 21
2022
|
Sebastien Robitaille Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
8,000
+17.98%
|
-
|
|
Nov 21
2022
|
Pharis Mohideen Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
17,500
+25.29%
|
-
|
|
Jul 29
2022
|
Pharis Mohideen Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
10,000
+22.62%
|
-
|
|
Jun 13
2022
|
Baker Bros. Advisors LP Director |
BUY
Grant, award, or other acquisition
|
Indirect |
11,875,000
+43.15%
|
-
|
|
Nov 22
2021
|
Sebastien Robitaille Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
5,000
+14.93%
|
-
|
|
Nov 22
2021
|
Pharis Mohideen Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
8,700
+26.44%
|
-
|